Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
After the first developed PARP inhibitor, olaparib, multiple PARP inhibitors such as niraparib, veliparib, and talazoparib were subsequently developed and tested in different phases of clinical trials
Accessed 5 Oct 2018
The data regarding the isolation and synthesis of BPC 157 come from a single laboratory and have not been reproduced
Insurance providers such as United Healthcare, Cigna, Blue Cross Blue Shield, and Aetna may offer coverage
Bypassing digestive barriers can make it easier for nutrients to be absorbed
July 11, 2025
US$ 21.09
US$ 29.81
US$ 21.49
US$ 28.27
US$ 21.70
US$ 22.81
US$ 25.50
